PRINCIPAL FINANCIAL GROUP INC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 169 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$21,669,548
-18.1%
416,002
-0.4%
0.02%
-11.1%
Q2 2023$26,457,250
+1994.6%
417,834
+1691.3%
0.02%
+1700.0%
Q1 2023$1,263,103
-4.3%
23,326
-6.4%
0.00%0.0%
Q4 2022$1,319,243
-38.2%
24,929
-45.7%
0.00%
-50.0%
Q3 2022$2,135,000
-80.6%
45,876
-76.1%
0.00%
-75.0%
Q2 2022$10,978,000
+171.8%
192,341
+191.4%
0.01%
+166.7%
Q1 2022$4,039,000
+15.9%
66,003
-0.9%
0.00%
+50.0%
Q4 2021$3,485,000
+197.9%
66,580
+112.2%
0.00%
+100.0%
Q3 2021$1,170,000
-4.4%
31,372
+4.6%
0.00%0.0%
Q2 2021$1,224,000
+46.6%
29,980
+21.8%
0.00%0.0%
Q1 2021$835,000
+14.7%
24,616
+7.5%
0.00%0.0%
Q4 2020$728,000
+106.2%
22,892
+66.2%
0.00%
Q3 2020$353,000
-1.7%
13,775
-1.4%
0.00%
Q2 2020$359,000
+30.1%
13,969
+73.4%
0.00%
Q4 2019$276,000
+11.7%
8,054
+75.0%
0.00%
Q4 2015$247,0004,6010.00%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 675,000$26,203,0007.44%
EcoR1 Capital, LLC 244,950$9,509,0003.75%
Redmile Group, LLC 971,565$37,716,0003.60%
Ghost Tree Capital, LLC 120,000$4,658,0001.34%
SENZAR ASSET MANAGEMENT, LLC 144,624$5,614,304,0001.22%
GREAT POINT PARTNERS LLC 100,000$3,882,0001.11%
BB BIOTECH AG 700,000$27,174,0001.07%
Rhenman & Partners Asset Management AB 115,000$4,464,0000.79%
Lisanti Capital Growth, LLC 12,260$476,0000.72%
Rock Springs Capital Management LP 190,000$7,376,0000.55%
View complete list of INTRA CELLULAR THERAPIES INC shareholders